These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 14570064)
1. Capecitabine in colorectal, breast, and other solid tumors: novel therapeutic approaches. Selected abstracts from ASCO 2003. Oncology (Williston Park); 2003 Aug; 17(8 Suppl 8):10-62; quiz 63-4. PubMed ID: 14570064 [No Abstract] [Full Text] [Related]
2. [Capecitabine in the treatment of colorectal cancer]. Zeuli M; Pino MS; Cognetti F Tumori; 2001; 87(1 Suppl 1):S55-6. PubMed ID: 11300027 [No Abstract] [Full Text] [Related]
3. [New therapeutic prospects with capecitabin in breast carcinoma]. Venturini M; Catzeddu T Tumori; 2002; 88(1):A1-6. PubMed ID: 12008671 [No Abstract] [Full Text] [Related]
4. Capecitabine in the treatment of colorectal cancer. O'Neill VJ; Cassidy J Future Oncol; 2005 Apr; 1(2):183-90. PubMed ID: 16555988 [TBL] [Abstract][Full Text] [Related]
6. [Doxifluridine for treatment of colorectal cancer]. Nishimura G; Miwa K Nihon Rinsho; 2003 Sep; 61 Suppl 7():345-8. PubMed ID: 14574909 [No Abstract] [Full Text] [Related]
7. [Capecitabine in colorectal carcinoma: news from ASCO 2008]]. Longo F; Mansueto G Tumori; 2008; 94(4):suppl 15-23. PubMed ID: 18822712 [No Abstract] [Full Text] [Related]
8. Capecitabine: indications and future perspectives in the treatment of metastatic colorectal and breast cancer. Cassata A; Procoplo G; Alù M; Ferrari L; Ferrario E; Beretta E; Longarini R; Busto G; De Candis D; Bajetta E Tumori; 2001; 87(6):364-71. PubMed ID: 11989587 [TBL] [Abstract][Full Text] [Related]
9. [The potential of capecitabine (Xeloda) in the treatment of disseminated solid tumors]. Moiseenko VM; Semenova AI; Orlova RV Vopr Onkol; 2001; 47(1):112-9. PubMed ID: 11317529 [No Abstract] [Full Text] [Related]
10. First-line capecitabine is as effective as 5-fluorouracil/leucovorin in treating advanced colorectal cancer. Gambill BD Clin Colorectal Cancer; 2001 May; 1(1):18-9. PubMed ID: 12445375 [No Abstract] [Full Text] [Related]
12. Oral versus intravenous fluoropyrimidines for advanced colorectal cancer: by either route, it's all the same. Mayer RJ J Clin Oncol; 2001 Nov; 19(21):4093-6. PubMed ID: 11689576 [No Abstract] [Full Text] [Related]
13. X-ACT: an important step on an unfinished journey. Maughan T Ann Oncol; 2012 Jul; 23(7):1655-8. PubMed ID: 22517823 [No Abstract] [Full Text] [Related]
14. Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer. Aprile G; Mazzer M; Moroso S; Puglisi F Anticancer Drugs; 2009 Apr; 20(4):217-29. PubMed ID: 19247178 [TBL] [Abstract][Full Text] [Related]
15. Penetration of capecitabine and its metabolites into malignant and healthy tissue of patients with advanced breast cancer. Mader RM; Schrolnberger C; Rizovski B; Brunner M; Wenzel C; Locker G; Eichler HG; Mueller M; Steger GG Int J Clin Pharmacol Ther; 2002 Dec; 40(12):571-2. PubMed ID: 12503818 [No Abstract] [Full Text] [Related]
17. Pharmacokinetic evaluation of capecitabine in breast cancer. Daniele G; Gallo M; Piccirillo MC; Giordano P; D'Alessio A; Del Giudice A; La Porta ML; Perrone F; Normanno N; De Luca A Expert Opin Drug Metab Toxicol; 2013 Feb; 9(2):225-35. PubMed ID: 23301520 [TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of capecitabine as adjuvant or metastatic therapy in colorectal cancer. Best JH; Garrison LP Expert Rev Pharmacoecon Outcomes Res; 2010 Apr; 10(2):103-14. PubMed ID: 20384557 [TBL] [Abstract][Full Text] [Related]
19. [Oral fluoropyrimidines in the treatment of colorectal carcinoma]. Porschen R Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S121-3. PubMed ID: 12817344 [No Abstract] [Full Text] [Related]
20. Capecitabine in the treatment of colorectal cancer. Kelly C; Cassidy J Expert Rev Anticancer Ther; 2007 Jun; 7(6):803-10. PubMed ID: 17555390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]